Wenliang Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wenliang Chen has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Yang Shen
Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430060, China
4 shared publications - Yangtao Xu
Department of Oncology, Renmin Hospital of Wuhan University, Wuhan 430060, China
4 shared publications - Ximing Xu
Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430060, China
3 shared publications - Xin Liu
Department of Oncology, Renmin Hospital of Wuhan University, Wuhan 430060, China
3 shared publications - Xinyao Hu
Department of Oncology, Renmin Hospital of Wuhan University, Wuhan 430060, China
3 shared publications - Jiayu Chen
Department of Oncology, Renmin Hospital of Wuhan University, Wuhan 430060, China
2 shared publications
Latest Publications
- Open Access
Overexpression of YEATS2 Remodels the Extracellular Matrix to Promote Hepatocellular Carcinoma Progression via the PI3K/AKT Pathway
Hepatocellular carcinoma (HCC) is one of the most common cancers and the fourth leading cause of death in men. YEATS domain containing 2 (YEATS2) gene encodes a scaffolding subunit of the ATAC complex. We found that YEATS2 was upregulated in HCC tissues and was associated with a poor prognosis. However, the role of YEATS2 in HCC remains unclear. The purpose of this study was to investigate the effect of YEATS2 on the progression of HCC and to elucidate its related mechanisms. We found that overexpression of YEATS2 promoted tumor cell proliferation, migration, and invasion through the PI3K/AKT signaling pathway and regulation of extracellular matrix. These findings help to understand the role of YEATS2 in HCC, and YEATS2 may become a new target for HCC therapy.
Open AccessOverexpression of YEATS2 Remodels the Extracellular Matrix to Promote Hepatocellular Carcinoma Progression via the PI3K/AKT Pathway
Hepatocellular carcinoma (HCC) is one of the most common cancers and the fourth leading cause of death in men. YEATS domain containing 2 (YEATS2) gene encodes a scaffolding subunit of the ATAC complex. We found that YEATS2 was upregulated in HCC tissues and was associated with a poor prognosis. However, the role of YEATS2 in HCC remains unclear. The purpose of this study was to investigate the effect of YEATS2 on the progression of HCC and to elucidate its related mechanisms. We found that overexpression of YEATS2 promoted tumor cell proliferation, migration, and invasion through the PI3K/AKT signaling pathway and regulation of extracellular matrix. These findings help to understand the role of YEATS2 in HCC, and YEATS2 may become a new target for HCC therapy.
- Open Access
- 16 September 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (18) , 10823
Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers
Malignant tumors are always a critical threat to human health, with complex pathogenesis, numerous causative factors, and poor prognosis. The features of cancers, such as gene mutations, epigenetic alterations, and the activation and inhibition of signaling pathways in the organism, play important roles in tumorigenesis and prognosis. MicroRNA (miRNA) enables the control of various molecular mechanisms and plays a variety of roles in human cancers, such as radiation sensitivity and tumor immunity, through the regulation of target genes. MiR-149-5p participates in the process and is closely related to lipogenesis, the migration of vascular endothelial cells, and the expression of stem-cell-related proteins. In recent years, its role in cancer has dramatically increased. In this review, we summarize the regular physiological roles of miRNAs, specifically miR-149-5p, in the organism and discuss the tumor-suppressive or oncogenic roles of miR-149-5p in different human cancers with respect to signaling pathways involved in regulation. Possible clinical applications of miR-149-5p in future targeted therapies and prognosis improvement in oncology are suggested.
- 16 September 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (18) , 10823
Open AccessTumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers
Malignant tumors are always a critical threat to human health, with complex pathogenesis, numerous causative factors, and poor prognosis. The features of cancers, such as gene mutations, epigenetic alterations, and the activation and inhibition of signaling pathways in the organism, play important roles in tumorigenesis and prognosis. MicroRNA (miRNA) enables the control of various molecular mechanisms and plays a variety of roles in human cancers, such as radiation sensitivity and tumor immunity, through the regulation of target genes. MiR-149-5p participates in the process and is closely related to lipogenesis, the migration of vascular endothelial cells, and the expression of stem-cell-related proteins. In recent years, its role in cancer has dramatically increased. In this review, we summarize the regular physiological roles of miRNAs, specifically miR-149-5p, in the organism and discuss the tumor-suppressive or oncogenic roles of miR-149-5p in different human cancers with respect to signaling pathways involved in regulation. Possible clinical applications of miR-149-5p in future targeted therapies and prognosis improvement in oncology are suggested.
- Open Access
- 30 March 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (4) , 858
Tubulin Alpha 1b Is Associated with the Immune Cell Infiltration and the Response of HCC Patients to Immunotherapy
Tubulin alpha 1b (TUBA1B) is an important microtubule isoform that is involved in the formation of the cytoskeleton. The objective of our study was to explore the potential of TUBA1B in predicting the prognosis of HCC and patients’ response to immunotherapy. Raw data was extracted from TCGA and GEO databases, and then HCCDB, TIMER, HPA, and GEPIA websites, as well as R software, were used to perform bioinformatics analysis to investigate the potential of TUBA1B as a prognostic and immunotherapeutic marker for hepatocellular carcinoma (HCC). We found that both TUBA1B mRNA and protein were highly expressed in HCC. TUBA1B was proved to be an independent prognostic predictor of HCC. Additionally, TUBA1B expression was associated with the infiltration of several immune cells in HCC. Moreover, TUBA1B was coexpressed with immune-related genes and immune checkpoints. Patients expressing high TUBA1B responded better to immune checkpoint inhibitor (ICI) therapy. GO and KEGG analyses revealed that TUBA1B may be involved in the processes of cell cycle, spliceosome, and DNA replication. In conclusion, TUBA1B is expected to be a prognostic and immunotherapeutic marker for HCC.
- 30 March 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (4) , 858
Open AccessTubulin Alpha 1b Is Associated with the Immune Cell Infiltration and the Response of HCC Patients to Immunotherapy
Tubulin alpha 1b (TUBA1B) is an important microtubule isoform that is involved in the formation of the cytoskeleton. The objective of our study was to explore the potential of TUBA1B in predicting the prognosis of HCC and patients’ response to immunotherapy. Raw data was extracted from TCGA and GEO databases, and then HCCDB, TIMER, HPA, and GEPIA websites, as well as R software, were used to perform bioinformatics analysis to investigate the potential of TUBA1B as a prognostic and immunotherapeutic marker for hepatocellular carcinoma (HCC). We found that both TUBA1B mRNA and protein were highly expressed in HCC. TUBA1B was proved to be an independent prognostic predictor of HCC. Additionally, TUBA1B expression was associated with the infiltration of several immune cells in HCC. Moreover, TUBA1B was coexpressed with immune-related genes and immune checkpoints. Patients expressing high TUBA1B responded better to immune checkpoint inhibitor (ICI) therapy. GO and KEGG analyses revealed that TUBA1B may be involved in the processes of cell cycle, spliceosome, and DNA replication. In conclusion, TUBA1B is expected to be a prognostic and immunotherapeutic marker for HCC.
- Open Access
- 1 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 4713518
ROS‐Related miRNAs Regulate Immune Response and Chemoradiotherapy Sensitivity in Hepatocellular Carcinoma by Comprehensive Analysis and Experiment
Reactive oxygen species (ROS) plays an essential role in the development of cancer. Here, we chose ROS‐related miRNAs for consensus clustering analysis and ROS score construction. We find that ROS is extremely associated with prognosis, tumor immune microenvironment (TIME), gene mutations, N6‐methyladenosine (m6A) methylation, and chemotherapy sensitivity in hepatocellular carcinoma (HCC). Mechanistically, ROS may affect the prognosis of HCC patients in numerous ways. Moreover, miR‐210‐3p and miR‐106a‐5p significantly increased the ROS level and stagnated cell cycle at G2/M in HCC; the results were more obvious in cells after ionizing radiation (IR). Finally, the two miRNAs suppressed cell proliferation, migration, and invasion and promoted apoptosis in huh7 and smmc7721 cells. It indicated that ROS might affect the prognosis of HCC patients through immune response and increase the sensitivity of HCC patients to radiotherapy and chemotherapy.
- 1 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 4713518
Open AccessROS‐Related miRNAs Regulate Immune Response and Chemoradiotherapy Sensitivity in Hepatocellular Carcinoma by Comprehensive Analysis and Experiment
Reactive oxygen species (ROS) plays an essential role in the development of cancer. Here, we chose ROS‐related miRNAs for consensus clustering analysis and ROS score construction. We find that ROS is extremely associated with prognosis, tumor immune microenvironment (TIME), gene mutations, N6‐methyladenosine (m6A) methylation, and chemotherapy sensitivity in hepatocellular carcinoma (HCC). Mechanistically, ROS may affect the prognosis of HCC patients in numerous ways. Moreover, miR‐210‐3p and miR‐106a‐5p significantly increased the ROS level and stagnated cell cycle at G2/M in HCC; the results were more obvious in cells after ionizing radiation (IR). Finally, the two miRNAs suppressed cell proliferation, migration, and invasion and promoted apoptosis in huh7 and smmc7721 cells. It indicated that ROS might affect the prognosis of HCC patients through immune response and increase the sensitivity of HCC patients to radiotherapy and chemotherapy.
- Open Access
- 1 January 2005
- Published by Optica Publishing Group in Optics Express
- Vol. 13 (18) , 6887-6891
Quantitative effect of temperature to the absorbance of aqueous glucose in wavelength range from 1200nm to 1700nm
In this paper, to find the quantitative errors of aqueous glucose induced by the temperature change at every wave point ranging from 1200nm to 1700nm, the calibration curve is calculated and shown. During the measurement the temperature varies from 30□ to 40□, at a 2□ interval, and aqueous glucose concentration ranges from 100mg/dL to 500mg/dL, at a interval of 100mg/dL. The absorption of aqueous glucose decreases with the increasing of temperature, also the absorbance decreases. In addition, only 1□ change in the temperature induces about -7×10-3 and -4×10-3 errors in the absorbance of the aqueous glucose at the wavelength of 1550nm, 1610nm respectively. So the examined result should be correct according to the data read from the calibration curve if the temperatures of modeling and measuring are not uniform. Using this method, the error caused by the temperature change can be reduced even eliminated.
- 1 January 2005
- Published by Optica Publishing Group in Optics Express
- Vol. 13 (18) , 6887-6891
Open AccessQuantitative effect of temperature to the absorbance of aqueous glucose in wavelength range from 1200nm to 1700nm
In this paper, to find the quantitative errors of aqueous glucose induced by the temperature change at every wave point ranging from 1200nm to 1700nm, the calibration curve is calculated and shown. During the measurement the temperature varies from 30□ to 40□, at a 2□ interval, and aqueous glucose concentration ranges from 100mg/dL to 500mg/dL, at a interval of 100mg/dL. The absorption of aqueous glucose decreases with the increasing of temperature, also the absorbance decreases. In addition, only 1□ change in the temperature induces about -7×10-3 and -4×10-3 errors in the absorbance of the aqueous glucose at the wavelength of 1550nm, 1610nm respectively. So the examined result should be correct according to the data read from the calibration curve if the temperatures of modeling and measuring are not uniform. Using this method, the error caused by the temperature change can be reduced even eliminated.